These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37486347)

  • 1. Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020-June 30, 2022.
    Falender RA; Mitchell PG; Guzman-Cottrill JA; Cieslak PR; Sutton M
    Emerg Infect Dis; 2023 Aug; 29(8):1672-1675. PubMed ID: 37486347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children: Results from the school-based cohort study Ciao Corona in November-December 2021 in the canton of Zurich.
    Haile SR; Raineri A; Rueegg S; Radtke T; Ulyte A; Puhan MA; Kriemler S
    Swiss Med Wkly; 2023 Jan; 153():40035. PubMed ID: 36787493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
    Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
    JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.
    Ladhani SN; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Walker J; Andrews N; Ireland G; Aiano F; Amin-Chowdhury Z; Letley L; Flood J; Jones SEI; Borrow R; Linley E; Zambon M; Poh J; Saliba V; Amirthalingam G; Lopez Bernal J; Brown KE; Ramsay ME
    Lancet Child Adolesc Health; 2021 Jun; 5(6):417-427. PubMed ID: 33740430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study.
    Callies M; Kabouche I; Desombere I; Merckx J; Roelants M; Vermeulen M; Duysburgh E
    BMC Public Health; 2023 May; 23(1):898. PubMed ID: 37194008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.
    Ulyte A; Radtke T; Abela IA; Haile SR; Blankenberger J; Jung R; Capelli C; Berger C; Frei A; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
    BMJ Open; 2021 Jul; 11(7):e047483. PubMed ID: 34312201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children.
    Powell AA; Ireland G; Leeson R; Lacey A; Ford B; Poh J; Ijaz S; Shute J; Cherepanov P; Tedder R; Bottomley C; Dawe F; Mangtani P; Jones P; Nguipdop-Djomo P; Ladhani SN;
    J Infect; 2023 Apr; 86(4):361-368. PubMed ID: 36803676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland.
    Ulyte A; Haile SR; Blankenberger J; Radtke T; Puhan MA; Kriemler S
    Swiss Med Wkly; 2022 Jun; 152():w30193. PubMed ID: 35752960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020.
    Sutton M; Cieslak P; Linder M
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(32):1100-1101. PubMed ID: 32790658
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens.
    Ma KC; Hale JE; Grad YH; Alter G; Luzuriaga K; Eaton RB; Fischinger S; Kaur D; Brody R; Siddiqui SM; Leach D; Brown CM; Klevens RM; Madoff L; Comeau AM
    Clin Infect Dis; 2022 Aug; 75(1):e105-e113. PubMed ID: 35213690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Increases and Seroprevalence by Type of Clinical CareSeptember 2021 to February 2022.
    Clarke KEN; Kim Y; Jones J; Lee A; Deng Y; Nycz E; Iachan R; Gundlapalli AV; MacNeil A; Hall A
    J Infect Dis; 2023 Feb; 227(3):364-370. PubMed ID: 36281757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.
    Damjanovic A; Styer LM; Nemeth K; Yauney E; Rock JM; Bievenue R; Hoen R; Ehrbar D; Kay DM; Caggana M; Parker MM
    JAMA Netw Open; 2022 Aug; 5(8):e2227995. PubMed ID: 35994287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.
    Dimopoulou D; Kyritsi M; Dadouli K; Vergadi E; Tsiligianni E; Papadimitriou E; Mavridi A; Giannakopoulos S; Tsiourvopoulou G; Palyvou M; Angeli E; Brikos N; Eleftheriou I; Spoulou V; Michos A; Gkentzi D; Siomou E; Papaevangelou V; Grivea I; Syrogiannopoulos G; Galanakis E; Hadjichristodoulou C; Tsolia M
    Eur J Pediatr; 2023 Jan; 182(1):439-449. PubMed ID: 36383284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.
    Kugeler KJ; Podewils LJ; Alden NB; Burket TL; Kawasaki B; Biggerstaff BJ; Biggs HM; Zacks R; Foster MA; Lim T; McDonald E; Tate JE; Herlihy RK; Drobeniuc J; Cortese MM
    Public Health Rep; 2022; 137(1):128-136. PubMed ID: 34752156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022.
    Kinoshita R; Arashiro T; Kitamura N; Arai S; Takahashi K; Suzuki T; Suzuki M; Yoneoka D
    Emerg Infect Dis; 2023 Sep; 29(9):1868-1871. PubMed ID: 37506681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does school reopening affect SARS-CoV-2 seroprevalence among school-age children in Milan?
    Barcellini L; Forlanini F; Sangiorgio A; Gambacorta G; Alberti L; Meta A; Gaia P; Amendola A; Tanzi E; Massa V; Borghi E; Fabiano V; Zuccotti GV
    PLoS One; 2021; 16(9):e0257046. PubMed ID: 34473776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Seroprevalence in Children from Western Romania, March to June 2021.
    Olariu TR; Craciun AC; Vlad DC; Dumitrascu V; Pop LL; Horhat F; Lupu MA
    Vector Borne Zoonotic Dis; 2022 Apr; 22(4):267-270. PubMed ID: 35384727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
    Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
    Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.